References

• 2003Measuring inconsistency in meta-analyses63,086 cited
• 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
• 1990The relation between alcohol problems and the anxiety disorders724 cited
• 2000Construct validation of the hospital anxiety and depression scale with clinical populations382 cited
• 2000Ecstasy (MDMA): a review of its possible persistent psychological effects380 cited
• 2001Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research344 cited
• 1997Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low283 cited
• 2000Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users279 cited
• 2001Cognitive performance and serotonergic function in users of ecstasy233 cited
• 2001Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?227 cited
• 2001Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems210 cited
• 2003Altered states: the clinical effects of Ecstasy190 cited
• 2003Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users171 cited
• 2002Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users